𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I study

✍ Scribed by Everett E. Vokes; James W. Raschko; Nicholas J. Vogelzang; Elizabeth E. Warfield; Mark J. Ratain; James H. Doroshow; Richard L. Schilsky

Publisher
Springer
Year
1991
Tongue
English
Weight
583 KB
Volume
28
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A phase II trial of weekly high dose con
A phase II trial of weekly high dose continuous infusion 5-fluorouracil plus oral leucovorin in patients with advanced colorectal cancer
✍ Enrique Aranda; AndrΓ©s Cervantes; Javier Dorta; Esperanza Blanco; Carlos FernΓ‘nd πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 419 KB πŸ‘ 2 views

Background. In a previous Phase I1 trial, the authors showed that a weekly continuous infusion of 5-fluorouracil (5-FU) at a dose of 3.5 g/mz for 48 hours is an active treatment for advanced colorectal cancer. The overall response rate was 38.5%, and the median survival was 12 months. These data wer

A phase I clinical trial of combined flu
A phase I clinical trial of combined fluoropyrimidines with leucovorin in a 14-day infusion. Demonstration of biochemical modulation
✍ N. Anderson; J. Lokich; M. Bern; S. Wallach; C. Moore; D. Williams πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 469 KB πŸ‘ 2 views

Two consecutive Phase I trials of continuous infusion 5-fluorouracil (5-FU) or floxuridine (5-FUdR) admixed with leucovorin (LCV) were performed and involved 19 and 24 patients, respectively. The studies were carried out to identify the optimal dose rate of delivery for the two admixtures (5-FU + LC